- 01ALA's evidence is narrow, and its rare risk is the opposite of what people expect
The one use with decent trials is easing nerve symptoms in diabetic neuropathy at 600 mg a day; the antioxidant, energy and weight claims are lab findings or tiny effects. And the serious risk people do not expect from a blood-sugar supplement is a rare immune reaction that causes repeated low blood sugar, often overnight, in people who may not even have diabetes. It resolves after stopping, but only if someone connects it to the capsule.
Alpha-lipoic acid (ALA) is a compound your cells make in tiny amounts and use inside mitochondria to turn food into energy. As a supplement, its best evidence is for one specific use: easing burning, stabbing and numb feet in people with diabetic polyneuropathy, the nerve damage diabetes can cause. In a 5-week trial, 600 mg a day halved the symptom score in 62% of people, against 26% on placebo 1. For blood sugar and weight, pooled trials found changes too small to matter on their own 45, and the antioxidant and energy claims come mostly from lab work 3.
What is alpha-lipoic acid?
Alpha-lipoic acid is a small sulfur-containing molecule your body makes, where it helps the enzymes that turn food into usable energy 3; what it is and what it does in your body has its own page. This guide covers what it is good for and how strong the evidence is, nerve comfort, blood sugar and weight, R-lipoic acid versus regular, how much studies use, when to take it, and its side effects, interactions and blood tests.
Supplements are different: they hold free (unbound) lipoic acid, usually 50 to 600 mg, likely up to 1,000 times what a diet provides 3. Most contain a racemic mixture, an equal blend of the natural R form and its mirror-image S form, and some sell R-lipoic acid alone 3. In Germany, lipoic acid is a prescription medicine for diabetic neuropathy; in the US it is a dietary supplement 3.
Is ALA an antioxidant?
In the test tube, lipoic acid and its reduced form, dihydrolipoic acid, neutralize reactive molecules called free radicals and help recycle other antioxidants such as vitamin C and glutathione, the cell's own main antioxidant 3. Whether that happens in the body is unknown: the Linus Pauling Institute notes that the highest tissue levels oral supplements reach are at least 10 times lower than those of vitamin C and glutathione, and that the rise in plasma is brief 3. That is why we grade the general antioxidant and energy claims as Early.
What alpha-lipoic acid is good for: the evidence, graded
Grades: Strong (several good randomized trials or a meta-analysis agree), Moderate (several randomized trials, mostly positive, but small or short), Limited (few or small trials, or mixed results), Early (lab, animal or one pilot study only), Not supported (good trials found no benefit). Our guide to how to judge a supplement explains why a grade matters more than a list of studies.
| Use | What the research found | Evidence | Source |
|---|---|---|---|
| Nerve symptoms in diabetic neuropathy (burning, tingling, numbness) | 5 weeks of 600 mg a day: symptom score halved in 62% vs 26% on placebo; pooled trials agree on symptoms | Moderate | 111 |
| Slowing nerve damage over years | 4-year trial: no change in the main nerve-test score; less worsening on a clinical exam | Limited | 2 |
| Blood sugar in type 2 diabetes | 16 trials: HbA1c down about 0.3 points; below a clinically important change | Limited | 4 |
| Weight | 10 trials: about 1.3 kg (under 3 pounds) more lost than placebo, short term | Limited | 5 |
| Inflammation (CRP) | CRP fell in pooled diabetes trials, but not by a clinically important amount | Limited | 4 |
| Antioxidant, energy or anti-aging in healthy people | Shown in test tubes and animals; tissue levels from capsules are low and brief | Early | 3 |
Nerve comfort: what the trials found
Diabetic polyneuropathy is nerve damage from long-term high blood sugar, usually felt first as burning, stabbing, tingling or numb feet. It is diagnosed and managed by a clinician, and keeping blood sugar in range is the core of care 3. ALA is not a treatment for it, and the trials below describe what was measured in people who already had it.
The best-known oral trial, SYDNEY 2, randomly assigned 181 adults with diabetes and nerve symptoms to 600, 1,200 or 1,800 mg of ALA once daily, or placebo, for 5 weeks 1. The total symptom score (stabbing pain, burning pain, pins and needles, and numbness in the feet) fell by 51%, 48% and 52% in the three ALA groups, against 32% on placebo 1. Higher amounts did not work better, but they did cause more nausea, vomiting and vertigo, so the authors judged 600 mg a day the best balance 1.
The long-term picture is less clear. In NATHAN 1, 460 adults with mild to moderate diabetic nerve damage took 600 mg a day or placebo for 4 years 2. The main combined score, built from a clinical exam and seven nerve tests, did not differ between groups, partly because it barely worsened on placebo either; the clinical exam score did favor ALA, with fewer people getting worse 2. A 2024 network meta-analysis (a review that compares several options across trials) found 600 mg a day lowered symptom scores against control, with stomach upset the most common side effect 11.
Oral treatment with ALA for 5 weeks improved neuropathic symptoms and deficits in patients with DSP. An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.
One honest caveat: the Linus Pauling Institute points out that many of these trials were run by one German research group and funded by a German maker of lipoic acid 3. That does not make them wrong, but it is worth knowing. Numb or burning feet also have causes other than diabetes, including low vitamin B12, which is common on long-term metformin; our B12 deficiency guide explains why that is worth ruling out with a clinician.
Does alpha-lipoic acid lower blood sugar?
A little. A 2022 dose-response meta-analysis of 16 trials with 1,035 adults with type 2 diabetes found ALA lowered HbA1c (a three-month blood sugar average), fasting glucose, triglycerides and CRP, with HbA1c about 0.32 points lower 4. The authors' verdict was blunt: every estimate fell below the smallest change that matters clinically 4. An earlier trial in 72 people with type 2 diabetes found 600 to 1,800 mg a day improved insulin sensitivity by about 25% after four weeks 3.
Type 2 diabetes and prediabetes are diagnosed and treated by a clinician. ALA is not a treatment for either and is never a swap for a prescribed medicine. If your own HbA1c or glucose came back high, bring it to your clinician first; our blood sugar tests guide explains each number.
Does alpha-lipoic acid help with weight loss?
Only slightly. A 2017 meta-analysis of 10 randomized placebo-controlled trials found ALA was linked to 1.27 kg (under 3 pounds) more weight loss than placebo and a BMI 0.43 points lower, over short periods, with no clear link to dose 5. The 2022 diabetes analysis found about 0.3 kg at 600 mg a day 4. Neither result makes ALA a weight-loss tool.
R-lipoic acid vs regular alpha-lipoic acid
R-ALA is the natural form; regular ALA is a 50:50 mix of R and S. After a dose of the mix, R reached peak blood levels 40% to 50% higher than S, which suggests R is absorbed better 310. But no published study has directly compared the bioavailability of R-ALA supplements with the mix, and the large nerve trials used the racemic mix 13.
R-ALA vs regular (racemic) ALA: the trials used the mix
How much alpha-lipoic acid do studies use?
| Use studied | Amount studied | Schedule | How long | Source |
|---|---|---|---|---|
| Diabetic nerve symptoms (SYDNEY 2) | 600, 1,200 or 1,800 mg a day | Once daily | 5 weeks | 1 |
| Diabetic nerve damage (NATHAN 1) | 600 mg a day | Once daily | 4 years | 2 |
| Blood sugar, type 2 diabetes (pooled) | Analyzed per 500 mg a day; benefits flattened above about 600 mg | Varied | Weeks to months | 4 |
| Insulin sensitivity | 600 to 1,800 mg a day | Varied | 4 weeks | 3 |
| Pregnancy (observational) | 600 mg a day | Daily | At least 7 weeks | 8 |
| Absorption study | 50 to 600 mg single doses | Single dose | 1 day | 10 |
There is no recommended intake and no official upper limit for ALA. Side effects rose with dose in SYDNEY 2, and 1,200 and 1,800 mg added side effects without adding benefit 1. Oral amounts up to 1,800 mg a day for six months and 1,200 mg a day for two years were used in neuropathy trials without serious adverse effects 3. One LifeFrom capsule holds 500 mg, a little under the 600 mg used in the main nerve trials.
When and how to take alpha-lipoic acid
ALA: absorbed better without food, and gone within hours
Lipoic acid is better absorbed on an empty stomach: food lowered the peak by about 30% and total exposure by about 20% 3. The trade-off is nausea, which can be worse without food. The LifeFrom label gives no rule about meals. Time of day has not been tested.
How long does alpha-lipoic acid take to work? In SYDNEY 2, symptom scores had fallen by the end of 5 weeks 1. For blood sugar, any change would show on an HbA1c after about three months (see our HbA1c guide). You will not feel an antioxidant effect.
What is the half-life of alpha-lipoic acid?
About 30 minutes. In healthy volunteers, oral doses of 50 to 600 mg peaked within 0.5 to 1 hour and then fell steeply, with a half-life of about 0.5 hours 10. ALA does not build up in the blood, which is why trials gave it daily.
Alpha-lipoic acid side effects
Nausea, vomiting and dizziness (vertigo) are the common ones, and they rise with dose 1. Over 4 years at 600 mg a day, people rated tolerability the same as placebo and stopped for side effects no more often, but serious adverse events were reported more often in the ALA group (38.1% against 28.0%); the trial did not attribute a specific cause 2.
| Common and usually mild | Rare, needs prompt or same-day care |
|---|---|
| Nausea, vomiting, dizziness, more likely at 1,200 mg and above 1 | Repeated low blood sugar (shakiness, sweating, racing heart, confusion, fainting), often overnight, early morning or hours after a meal: possible insulin autoimmune syndrome. Stop ALA, treat the low as your care plan says and get same-day care; call 911 for fainting, a seizure or confusion that does not clear 7 |
| Stomach upset, the most common complaint across neuropathy trials 11 | On insulin or other diabetes medicines: lows that are new or more frequent after starting ALA 3 |
The rare reaction: insulin autoimmune syndrome
Insulin autoimmune syndrome (IAS) is a rare condition in which the immune system makes antibodies to the body's own insulin. The antibodies hold insulin and then release it at the wrong time, causing low blood sugar. A 2021 review of 37 published ALA-linked cases found symptoms most often at night or early morning (61%) or late after meals (50%); median glucose at the time was 2.19 mmol/L (about 39 mg/dL), insulin was very high (100 µIU/mL or more in 95%), and the lows went away within 5 days to 8 months after stopping ALA, sometimes with steroid treatment 7.
The Panel concludes that the consumption of ALA added to foods, including food supplements, is likely to increase the risk of developing IAS in individuals with certain genetic polymorphisms, who cannot be readily identified without genetic testing.European Food Safety Authority, scientific opinion on alpha-lipoic acid and insulin autoimmune syndrome, 2021 6
The European Food Safety Authority reviewed 49 case reports and found IAS resolved in every one within weeks to months of stopping ALA 6. It could not name a safe dose, because the threshold seems to vary between people, and estimated the condition's incidence in Japan at about 0.017 per 100,000 people 6. Most incidence data come from Japan 6, and the 2021 review drew its 37 cases from Chinese- and English-language reports 7. It is rare, and it is also easy to miss: a person with no diabetes having lows at night may not connect them to a supplement.
Who should avoid alpha-lipoic acid or ask first
- Diabetes on insulin or other medicines: ALA may improve insulin sensitivity, so the Linus Pauling Institute advises close glucose monitoring if it is added 3. Changes to diabetes medicines belong with the prescriber.
- Thyroid medicine: a 1991 experimental study found lipoic acid given with thyroxine (T4) cut the conversion of T4 into T3, the active thyroid hormone, by up to 56% 9. We found no good study in people, so ask the prescriber and keep thyroid tests up to date.
- Pregnancy: a retrospective study of 610 pregnant women taking 600 mg a day for at least 7 weeks found no harm to mothers or babies 8, but one observational study is not proof of safety; the Linus Pauling Institute advises use in pregnancy only under strict medical supervision 3.
- Breastfeeding: safety has not been established, and the Linus Pauling Institute advises against it 3.
- Children: not studied as a supplement.
- Cancer treatment: we found little data on how ALA mixes with chemotherapy or radiation, and antioxidants are a common question for oncology teams, so ask the care team first.
- Anyone with unexplained low blood sugar: tell the clinician about ALA, since it is a known trigger of IAS 6.
Alpha-lipoic acid interactions
| Medicine | What can happen | Why | What to do |
|---|---|---|---|
| Insulin and other diabetes medicines | Blood sugar may drop further | ALA may improve insulin-driven glucose use; a single-dose study with glyburide or acarbose found no interaction 3 | Talk to the prescriber first; they may want closer glucose checks |
| Levothyroxine and other thyroid hormone | Less active T3 made from T4, in one experimental study | Lipoic acid suppressed T4-to-T3 conversion by up to 56% in that study 9 | Ask the prescriber whether thyroid tests should be rechecked |
| Chemotherapy and radiation | Unknown | Little published data on antioxidants alongside cancer treatment | Ask the oncology team before starting |
| Lab tests for low blood sugar | Very high insulin readings can prompt pancreas scans; in reported IAS cases the scans were normal | IAS antibodies raise measured insulin 7 | Tell the clinician about ALA before any low-blood-sugar workup |
Supplements to pair or keep apart
| Supplement | Together or apart | Why |
|---|---|---|
| Biotin | Usually fine; worth knowing | The two molecules look alike; high-dose ALA injections in rats cut the activity of biotin-dependent enzymes by 30% to 35%, but whether oral ALA raises biotin needs in people is unknown 3 |
| Chromium and Trace Minerals | Ask first if on diabetes medicines | Both are sold for blood sugar; LifeFrom's Trace Minerals capsule (in the Antioxidants pack) holds 200 mcg of chromium |
| Berberine | Ask first | A stronger glucose-lowering supplement; effects may add |
| NAC | Together in the Antioxidants pack | Both are sulfur compounds linked to glutathione; no trial of the pair |
| Vitamin C | Fine together | ALA helps recycle vitamin C in lab studies 3 |
| Vitamin B12 | Fine together | Not an interaction, but low B12 is a separate, testable cause of numb feet, especially on metformin |
Blood tests worth knowing about
No blood test measures ALA itself in routine care. The labs that matter are the ones it can move and the ones that pick up the rare problems. Ask your clinician whether any of these make sense for you.
| Marker | Why it matters with ALA | When it is usually checked |
|---|---|---|
| HbA1c | Fell about 0.3 points in pooled diabetes trials 4 | Every 3 to 6 months in diabetes |
| Fasting glucose | Worth watching on diabetes medicines; very low in IAS 7 | Routine bloods, or home checks |
| Fasting insulin and C-peptide | In IAS, insulin read 100 µIU/mL or more in 95% of cases; C-peptide is measured alongside it 7 | Only in a low-blood-sugar workup |
| hs-CRP | Fell slightly in diabetes trials 4 | Not routine; sometimes with heart risk testing |
| TSH and free T4 | Thyroid checks if on thyroid hormone, given the T4-to-T3 finding 9 | On the schedule the prescriber sets |
| Vitamin B12 | Not moved by ALA, but a cause of numb feet worth ruling out | When nerve symptoms are investigated |
If you have an HbA1c in hand, the A1C calculator converts it to average glucose, and the HOMA-IR calculator estimates insulin resistance from fasting glucose and insulin. Our inflammation markers guide explains CRP, and the thyroid panel guide explains TSH and free T4.
Conditions ALA comes up around
ALA comes up most around diabetic nerve damage, prediabetes and type 2 diabetes, and sometimes around hypothyroidism because of the thyroid question. Each is diagnosed and treated by a clinician. ALA is not a treatment for any of them, and it is never a swap for a prescribed medicine, including medicines for nerve pain.
Alpha-lipoic acid in the LifeFrom pouch
| In the LifeFrom pouch | |
|---|---|
| Product | Alpha Lipoic Acid |
| What one serving holds | Alpha Lipoic Acid 500 mg |
| Form | One vegan capsule (vegetable cellulose); the label does not say whether it is racemic or R-lipoic acid |
| How it is packed | One serving in each of your 30 daily pouches, with up to 8 supplements per pouch |
| Price | $12.00 a month, plus the fixed $28.50 a month packing, handling and US delivery line for the whole pouch, not per supplement. Prices as of November 2026; the shop shows the current price |
| Curated packs that include it | Antioxidants (with Trace Minerals, Quercetin, NAC, Vitamin C and Resveratrol) |
| Label notes | No instruction about meals; keep out of reach of children |
One capsule holds 500 mg, a little under the 600 mg a day used in the main nerve trials 12. Everything in a pouch is taken at once, so if the pouch goes down with breakfast, absorption will be somewhat lower than on an empty stomach 3. The Antioxidants pack also contains Trace Minerals, which holds 200 mcg of chromium, so anyone on diabetes medicines is taking two things sold for blood sugar together. See the shop and its packs.
This guide is general education, not medical advice. Dietary supplements are not FDA-approved for safety or effectiveness before they are sold 12. The clinician who knows your history and medicines is the right person to decide whether ALA fits, and new nerve symptoms deserve a proper workup rather than a supplement trial. Read our medical disclaimer for more.
Citations
- Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365-2370.
- Ziegler D, Low PA, Litchy WJ, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care. 2011;34(9):2054-2060.
- Linus Pauling Institute, Oregon State University. Lipoic acid. Micronutrient Information Center.
- Jibril AT, Jayedi A, Shab-Bidar S. Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials. Endocr Connect. 2022;11(10):e220322.
- Kucukgoncu S, Zhou E, Lucas KB, Tek C. Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials. Obes Rev. 2017;18(5):594-601.
- EFSA Panel on Nutrition, Novel Foods and Food Allergens. Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA J. 2021;19(6):e06577.
- Li Z, Su Y, Yi D, Wu C, Fang W, Wang C. Analysis of the clinical characteristics of insulin autoimmune syndrome induced by alpha-lipoic acid. J Clin Pharm Ther. 2021;46(4):1106-1113.
- Parente E, Colannino G, Picconi O, Monastra G. Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study. Eur Rev Med Pharmacol Sci. 2017;21(18):4219-4227.
- Segermann J, Hotze A, Ulrich H, Rao GS. Effect of alpha-lipoic acid on the peripheral conversion of thyroxine to triiodothyronine and on serum lipid-, protein- and glucose levels. Arzneimittelforschung. 1991;41(12):1294-1298.
- Breithaupt-Grögler K, Niebch G, Schneider E, et al. Dose-proportionality of oral thioctic acid: coincidence of assessments via pooled plasma and individual data. Eur J Pharm Sci. 1999;8(1):57-65.
- Prado MB, Adiao KJB. Ranking alpha lipoic acid and gamma linolenic acid in terms of efficacy and safety in the management of adults with diabetic peripheral neuropathy: a systematic review and network meta-analysis. Can J Diabetes. 2024;48(4):249-256.
- US Food and Drug Administration. Dietary supplements.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.
